Skip to main content
Article
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
All Scholarly Works
  • Edward Reiter, MD, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
7-1-2004
Abstract
Long-term GH replacement therapy is indicated for children with growth failure due to GH deficiency (GHD). We evaluated the feasibility of administering a long-acting GH preparation [Nutropin Depot (somatropin, rDNA origin) for injectable suspension] to p
Publication ISSN
0272-6386
Citation Information
J Clin Endocrinol Metab 2004 Jul;89(7):3234-40.